AEMD (STOCKS)
AETHLON MEDICAL INC
$2.040000
+0.020000 (+0.99%)
Prev close: $2.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James B. Frakes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.74M
- Employees
- 9
- P/E (TTM)
- -0.13
- P/B (TTM)
- 0.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$-2.45 | $-2.47 | +0.0184 | +0.75% |
|
Sep 2025 (Q2)
|
$-3.74 | $-3.74 | -0.0034 | -0.09% |
|
Jun 2025 (Q1)
|
$-8.50 | $-8.77 | +0.2720 | +3.10% |
|
Mar 2025 (Q4)
|
$-79.70 | $-10.30 | -69.3980 | -673.64% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $142.16K |
| Operating Expenses | $7.29M |
| Research and Development | $1.91M |
| Other Operating Expenses | $5.38M |
| Operating Income/Loss | -$7.29M |
| Income/Loss From Continuing Operations After Tax | -$7.15M |
| Income/Loss From Continuing Operations Before Tax | -$7.15M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$7.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$10.61 |
| Diluted Earnings Per Share | -$10.61 |
| Basic Average Shares | 673,945 |
| Diluted Average Shares | 673,945 |
| Assets | $6.33M |
| Current Assets | $5.57M |
| Noncurrent Assets | $763.57K |
| Fixed Assets | $356.82K |
| Other Non-current Assets | $406.75K |
| Liabilities | $1.45M |
| Current Liabilities | $1.45M |
| Accounts Payable | $384.55K |
| Other Current Liabilities | $1.06M |
| Noncurrent Liabilities | $0.00 |
| Equity | $4.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.89M |
| Liabilities And Equity | $6.33M |
| Net Cash Flow From Operating Activities | -$7.00M |
| Net Cash Flow From Operating Activities, Continuing | -$7.00M |
| Net Cash Flow From Investing Activities | -$3.70K |
| Net Cash Flow From Investing Activities, Continuing | -$3.70K |
| Net Cash Flow From Financing Activities | $6.52M |
| Net Cash Flow From Financing Activities, Continuing | $6.52M |
| Exchange Gains/Losses | $6.50K |
| Net Cash Flow | -$473.69K |
| Net Cash Flow, Continuing | -$480.19K |
| Comprehensive Income/Loss | -$7.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.17M |
| Other Comprehensive Income/Loss | -$15.57K |